Table 1.
Characteristics | No. of Pts (n=225, %) | hs-cTnT baseline (n=158) |
hs-cTnT delta (n=149) |
||
---|---|---|---|---|---|
mean (SD) | P | mean (SD) | P | ||
Age | <0.0001 | 0.683 | |||
<64 years | 90 (40) | 5.1 (3.7) | 3.0 (4.7) | ||
≥64 years | 135 (60) | 10.2 (11.7) | 4.1 (11.3) | ||
Sex | <0.0001 | 0.455 | |||
Female | 106 (47) | 6.3 (9.1) | 3.1 (6.5) | ||
Male | 119 (53) | 9.9 (10.0) | 4.3 (11.6) | ||
Race | 0.848 | 0.282 | |||
White | 204 (91) | 8.0 (9.5) | 3.8 (9.4) | ||
Other | 21 (9) | 10.1 (12.6) | 2.5 (9.1) | ||
Disease Stage | 0.902 | 0.902 | |||
II | 18 (8) | 10.7 (11.4) | 3.7 (6.1) | ||
IIIA | 91 (40) | 7.6 (8.9) | 2.2 (3.9) | ||
IIIB | 92 (41) | 8.5 (10.1) | 4.6 (12.8) | ||
IV | 10 (5) | 11.3 (16.8) | 7.3 (14.6) | ||
Recurrent | 14 (6) | 5.8 (3.5) | 3.9 (7.3) | ||
Tumor Histology | 0.065 | 0.428 | |||
Adeno | 118 (52) | 7.4 (8.3) | 4.5 (11.6) | ||
Squamous | 76 (34) | 7.9 (9.0) | 3.2 (3.7) | ||
Other | 31 (14) | 12.5 (15.2) | 1.3 (8.1) | ||
Gross Tumor Volume* | 0.191 | 0.651 | |||
≤126.5 cm3 | 147 (65) | 7.4 (7.6) | 4.2 (10.6) | ||
>126.5 cm3 | 77 (34) | 10.0 (13.1) | 2.5 (6.1) | ||
Tumor Location | 0.999 | 0.006 | |||
Left/ Mediastinal | 90 (40) | 7.0 (6.2) | 5.9 (12.1) | ||
Right | 130 (58) | 9.1 (11.7) | 2.1 (6.6) | ||
Other | 5 (2) | 5.6 (1.5) | 2.3 (2.7) | ||
KPS | 0.025 | 0.762 | |||
<80 | 26 (12) | 17.1 (20.2) | 1.8 (9.4) | ||
≥80 | 199 (88) | 7.2 (7.3) | 3.9 (9.3) | ||
Smoking Status | 0.334 | 0.889 | |||
Never | 18 (8) | 7.0 (5.9) | 4.0 (6.5) | ||
Previous | 159 (71) | 8.7 (9.6) | 3.3 (6.1) | ||
Current | 48 (21) | 7.3 (11.5) | 4.6 (16.3) | ||
Pre-existing heart disease | 0.0008 | 0.554 | |||
No | 182 (81) | 7.6 (9.7) | 3.8 (10.0) | ||
Yes | 43 (19) | 11.1 (9.8) | 2.8 (5.7) | ||
Modality | 0.622 | 0.088 | |||
PSPT† | 88 (39) | 9.3 (11.6) | 3.5 (13.0) | ||
IMRT | 137 (61) | 7.5 (8.3) | 3.8 (5.8) |
Abbreviations: Pts, patients; hs-cTnT, high-sensitivity cardiac troponin T; KPS, Karnofsky performance status score; PSPT, passively-scattered proton therapy; IMRT, intensity-modulated (photon) radiation therapy.
One patient had no information on gross tumor volume.
One patient was grouped in PSPT but was treated with 34 Gy PSPT first and 38 Gy IMRT later